# Peter Korsten

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/peter-korsten/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,158 |
| Field | Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis |
| h-index | 25 |
| i10-index | 62 |
| Last Known Institution | Voestalpine (Brazil) |
| OpenAlex ID | https://openalex.org/A5004103994 |
| ORCID iD | 0000-0001-6065-5680 |
| Works | 183 |

## Researcher papers

- [ERS clinical practice guidelines on treatment of sarcoidosis](https://scholariq.org/papers/ers-clinical-practice-guidelines-on-treatment-of-sarcoidosis/)
- [A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19](https://scholariq.org/papers/a-rush-to-judgment-rapid-reporting-and-dissemination-of-results-and-its/)
- [Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress](https://scholariq.org/papers/linking-alzheimer-s-disease-to-insulin-resistance-the-foxo-response-to-oxidative/)
- [Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment](https://scholariq.org/papers/methotrexate-associated-pneumonitis-and-rheumatoid-arthritis-interstitial-lung/)
- [Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury–to–chronic kidney disease progression](https://scholariq.org/papers/low-dose-hydralazine-prevents-fibrosis-in-a-murine-model-of-acute-kidney-injury/)
- [Tocilizumab in the treatment of rheumatoid arthritis and beyond](https://scholariq.org/papers/tocilizumab-in-the-treatment-of-rheumatoid-arthritis-and-beyond/)
- [Rheumatologic Manifestations of Sarcoidosis](https://scholariq.org/papers/rheumatologic-manifestations-of-sarcoidosis/)
- [Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐Analysis](https://scholariq.org/papers/antirheumatic-disease-therapies-for-the-treatment-of-covid-19-a-systematic/)
- [Management of extrapulmonary sarcoidosis: challenges and solutions](https://scholariq.org/papers/management-of-extrapulmonary-sarcoidosis-challenges-and-solutions/)
- [Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19](https://scholariq.org/papers/swinging-the-pendulum-lessons-learned-from-public-discourse-concerning/)
- [Belimumab for systemic lupus erythematosus – Focus on lupus nephritis](https://scholariq.org/papers/belimumab-for-systemic-lupus-erythematosus-focus-on-lupus-nephritis/)

## Researcher topics

- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Sarcoidosis and Beryllium Toxicity Research](https://scholariq.org/topics/sarcoidosis-and-beryllium-toxicity-research/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)

## Researcher university

- [Voestalpine (Brazil)](https://scholariq.org/institutions/voestalpine-brazil/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.